JAMES DANIEL SHOEMAKER, MD
Medical Practice in Saint Louis, MO
License number
Missouri R6H33
Category
Medical Practice
Type
Chemical Pathology
Address
Address
1402 SOUTH Grand St, Saint Louis, MO 63104
Phone
(314) 977-9230
(314) 977-4440
(314) 977-4440
Personal information
See more information about JAMES DANIEL SHOEMAKER at radaris.comName
Address
Phone
5294 W Farm Road 156, Springfield, MO 65802
5200 Old Millers Rd LOT 35, Columbia, MO 65201
5645 E Tim Trl, Joplin, MO 64801
414 Franklin Ave, Moberly, MO 65270
410 Morehead St, Moberly, MO 65270
Professional information
See more information about JAMES DANIEL SHOEMAKER at trustoria.com
James Daniel Shoemaker, Saint Louis MO
James Daniel Shoemaker, Saint Louis MO
Specialties:
Pathology, Chemical Pathology, General Practice, Internal Medicine, General Preventive Medicine
Work:
Saint Louis University
1402 S Grand Blvd, Saint Louis, MO 63104
1402 S Grand Blvd, Saint Louis, MO 63104
Dr. James D Shoemaker, Saint Louis MO - MD (Doctor of Medicine)
Dr. James D Shoemaker, Saint Louis MO - MD (Doctor of Medicine)
Specialties:
Dietetics, Internal Medicine, Nutrition
Address:
1402 S Grand Blvd SUITE RB4, Saint Louis 63104
(314) 977-9230 (Phone), (314) 977-6777 (Fax)
ST LOUIS UNIV SCHOOL OF MEDICINE
1402 S Grand Blvd, Saint Louis 63104
(314) 977-6195 (Phone), (314) 268-5117 (Fax)
(314) 977-9230 (Phone), (314) 977-6777 (Fax)
ST LOUIS UNIV SCHOOL OF MEDICINE
1402 S Grand Blvd, Saint Louis 63104
(314) 977-6195 (Phone), (314) 268-5117 (Fax)
Languages:
English
Education:
Medical School
University of Illinois At Chicago / College of Medicine
Graduated: 1981
University of Illinois At Chicago / College of Medicine
Graduated: 1981
Compounds, Compositions And Methods For Treating Erectile Dysfunction
Compounds, Compositions And Methods For Treating Erectile Dysfunction
US Patent:
6365590, Apr 2, 2002
Filed:
Aug 18, 2000
Appl. No.:
09/642502
Inventors:
James D. Shoemaker - Clayton MO
Assignee:
Saint Louis University - St. Louis MO
International Classification:
C07D23972
US Classification:
51425217, 514567, 514559, 514560, 514626, 544283, 554222, 564193
Abstract:
Vasoactive compounds are described for the treatment of erectile dysfunction and impotence. The compounds are reaction products of an anionic or negatively charged vasoactive or erection-inducing component (such as alprostadil) and a cationic or positively charged vasoactive or erection-inducing component (such as prazosin) or a local anesthetic (such as lidocaine). These components are combined as acids and bases to form an organic salt or ionically bonded compound. The compounds have advantageous solubility characteristics and efficacy. A compound of the invention is combined with a pharmaceutical vehicle to form a composition which preferably includes an emulsifier. A local anesthetic and/or androgenic steroids may also be included. Compositions of the invention may also include more than one vasoactive organic salt compound. The composition can be advantageously formulated and administered to allow self-adjusted dosing, while minimizing or preventing overdosing.
Compounds, Compositions, And Methods For Treating Erectile Dysfunction
Compounds, Compositions, And Methods For Treating Erectile Dysfunction
US Patent:
6124461, Sep 26, 2000
Filed:
May 26, 1998
Appl. No.:
9/084849
Inventors:
James D. Shoemaker - Clayton MO
Assignee:
Saint Louis University, Health Services Center, Research Administration - St. Louis MO
International Classification:
C07D21710, C07D23354
US Classification:
546147
Abstract:
Vasoactive compounds are described for the treatment of erectile dysfunction and impotence. The compounds are reaction products of an anionic or negatively charged vasoactive or erection-inducing component and a cationic or positively charged vasoactive or erection-inducing component. These components are combined as acids and bases to form an organic salt or ionically bonded compound. The compounds have advantageous solubility characteristics and efficacy. A compound of the invention is combined with a pharmaceutical vehicle to form a composition which preferably includes an emulsifier. A local anesthetic and/or androgenic steroids may also be included. Compositions of the invention may also include more than one vasoactive organic salt compound. The composition can be advantageously formulated and administered to allow self-adjusted dosing, while minimizing or preventing overdosing.
Polypeptides Useful For Appetite Suppression
Polypeptides Useful For Appetite Suppression
US Patent:
7544662, Jun 9, 2009
Filed:
Aug 5, 2005
Appl. No.:
11/198768
Inventors:
Ralph A. Nelson - Urbana IL, US
James D. Shoemaker - Clayton MO, US
James D. Shoemaker - Clayton MO, US
Assignee:
Carle Development Foundation - Urbana IL
International Classification:
A61K 38/00
US Classification:
514 12, 514 18, 514 19, 930 10
Abstract:
The present invention relates to polypeptides obtained from bear derivative isolate which are useful in suppressing appetite. The polypeptides of the present invention are most preferably between 12 and 13 amino acid residues in length and a mass of about 1249. The present invention also relates to a method of treating obesity by administering to obese subjects an effective amount of the polypeptides of the present invention.
Polypeptides Useful For Appetite Suppression
Polypeptides Useful For Appetite Suppression
US Patent:
2010029, Nov 18, 2010
Filed:
Feb 6, 2009
Appl. No.:
12/322801
Inventors:
Ralph A. Nelson - Urbana IL, US
James D. Shoemaker - Clayton MO, US
James D. Shoemaker - Clayton MO, US
International Classification:
C07K 7/00
US Classification:
530327
Abstract:
The present invention relates to polypeptides obtained from bear derivative isolate which are useful in suppressing appetite. The polypeptides of the present invention are most preferably between 12 and 13 amino acid residues in length and a mass of about 1249. The present invention also relates to a method of treating obesity by administering to obese subjects an effective amount of the polypeptides of the present invention.